Private Wealth Partners LLC acquired a new stake in The Procter & Gamble Company (NYSE:PG) in the second quarter, according to the company in its most recent filing with the SEC. The firm acquired 26,712 shares of the company’s stock, valued at approximately $3,604,000.
A number of other large investors have also bought and sold shares of PG. Traverso Chambers Private Wealth Management LLC lifted its holdings in shares of The Procter & Gamble by 0.4% during the second quarter. Traverso Chambers Private Wealth Management LLC now owns 53,128 shares of the company’s stock worth $7,169,000 after purchasing an additional 236 shares during the period. Empirical Financial Services LLC d.b.a. Empirical Wealth Management raised its position in The Procter & Gamble by 17.0% during the 2nd quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management now owns 26,958 shares of the company’s stock worth $3,637,000 after purchasing an additional 3,921 shares during the last quarter. Regentatlantic Capital LLC lifted its holdings in The Procter & Gamble by 0.9% during the 2nd quarter. Regentatlantic Capital LLC now owns 68,449 shares of the company’s stock worth $9,236,000 after buying an additional 638 shares during the period. Magellan Asset Management Ltd grew its position in shares of The Procter & Gamble by 566,378.0% in the 2nd quarter. Magellan Asset Management Ltd now owns 13,340,557 shares of the company’s stock valued at $1,800,041,000 after buying an additional 13,338,202 shares during the last quarter. Finally, Connor Clark & Lunn Investment Management Ltd. increased its stake in shares of The Procter & Gamble by 51.0% in the second quarter. Connor Clark & Lunn Investment Management Ltd. now owns 621,824 shares of the company’s stock valued at $83,903,000 after buying an additional 209,885 shares during the period. Institutional investors and hedge funds own 62.51% of the company’s stock.
NYSE:PG traded up $0.62 on Thursday, hitting $144.22. The stock had a trading volume of 282,712 shares, compared to its average volume of 7,986,192. The company has a quick ratio of 0.52, a current ratio of 0.70 and a debt-to-equity ratio of 0.50. The Procter & Gamble Company has a 52 week low of $121.54 and a 52 week high of $147.23. The business’s fifty day moving average is $142.67 and its 200 day moving average is $137.37. The company has a market cap of $350.21 billion, a PE ratio of 26.16, a P/E/G ratio of 3.47 and a beta of 0.43.
The firm also recently disclosed a quarterly dividend, which was paid on Monday, August 16th. Shareholders of record on Friday, July 23rd were paid a $0.8698 dividend. This represents a $3.48 dividend on an annualized basis and a dividend yield of 2.41%. This is a positive change from The Procter & Gamble’s previous quarterly dividend of $0.66. The ex-dividend date was Thursday, July 22nd. The Procter & Gamble’s dividend payout ratio (DPR) is 61.48%.
In related news, CEO Carolyn M. Tastad sold 7,772 shares of the business’s stock in a transaction dated Monday, August 2nd. The shares were sold at an average price of $141.77, for a total transaction of $1,101,836.44. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, Director Nelson Peltz sold 207,000 shares of The Procter & Gamble stock in a transaction that occurred on Tuesday, August 31st. The stock was sold at an average price of $142.43, for a total transaction of $29,483,010.00. The disclosure for this sale can be found here. Over the last three months, insiders have sold 748,024 shares of company stock valued at $106,760,698. 0.51% of the stock is currently owned by insiders.
Several analysts recently commented on the company. Truist Securities upped their target price on The Procter & Gamble from $140.00 to $145.00 and gave the company a “hold” rating in a report on Monday, August 2nd. Credit Suisse Group upped their price objective on shares of The Procter & Gamble from $135.00 to $145.00 and gave the company a “neutral” rating in a research note on Monday, August 2nd. Morgan Stanley lifted their target price on shares of The Procter & Gamble from $160.00 to $161.00 and gave the stock an “overweight” rating in a research note on Tuesday, September 7th. UBS Group began coverage on shares of The Procter & Gamble in a research report on Wednesday, June 23rd. They set a “neutral” rating and a $138.00 price target on the stock. Finally, Citigroup lifted their price objective on The Procter & Gamble from $150.00 to $154.00 and gave the stock a “neutral” rating in a research report on Monday, August 2nd. Ten research analysts have rated the stock with a hold rating and nine have given a buy rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of $151.63.
The Procter & Gamble Profile
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment comprises of shave care like female and male blades and razors, pre and post shave products, and appliances.
Recommended Story: Average Daily Trade Volume – What You Need to Know
Receive News & Ratings for The Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.